Cargando…

Remote Patient Monitoring for the Detection of COPD Exacerbations

BACKGROUND: COPD exacerbations occur more frequently with disease progression and are associated with worse prognosis and higher healthcare expenditure. PURPOSE: To utilize a networked system, optimized with statistical process control (SPC), for remote patient monitoring (RPM) and to identify poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Christopher B, Sirichana, Worawan, Arnold, Michael T, Neufeld, Eric V, Taylor, Michael, Wang, Xiaoyan, Dolezal, Brett A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519812/
https://www.ncbi.nlm.nih.gov/pubmed/33061338
http://dx.doi.org/10.2147/COPD.S256907
Descripción
Sumario:BACKGROUND: COPD exacerbations occur more frequently with disease progression and are associated with worse prognosis and higher healthcare expenditure. PURPOSE: To utilize a networked system, optimized with statistical process control (SPC), for remote patient monitoring (RPM) and to identify potential predictors of COPD exacerbations. METHODS: Seventeen subjects, mean (SD) age of 69.7 (7.2) years, with moderate to severe COPD received RPM. Over 2618 patient-days (7.17 patient-years) of monitoring, we obtained daily symptom scores, treatment adherence, self-reported activity levels, daily spirometry (SVC, FEV(1), FVC, PEF), inspiratory capacity (IC), and oxygenation (SpO(2)). These data were used to identify predictors of exacerbations defined using Anthonisen and other criteria. RESULTS: After implementation of SPC, concordance analysis showed substantial agreement between FVC (decrease below the 7-day rolling average minus 1.645 SD) and self-reported healthcare utilization events (κ=0.747, P<0.001) as well as between increased use of inhaled short-acting bronchodilators and exacerbations defined by two Anthonisen criteria (κ=0.611, P<0.001) or modified Anthonisen criteria (κ=0.622, P<0.001). There was a moderate agreement between FEV(1) (decrease >1.645 SD below the 7-day rolling average) and self-reported healthcare utilization events (κ=0.475, P<0.001) and between SpO(2) less than 90% and exacerbations defined by two Anthonisen criteria (κ=0.474, P<0.001) or modified Anthonisen criteria (κ=0.564, P<0.001). CONCLUSION: Exacerbations were best predicted by FVC and FEV(1) below the one-sided 95% confidence interval derived from SPC but also by increased use of inhaled short-acting bronchodilators and fall in oxygen saturation. An RPM program that captures these parameters may be used to guide appropriate interventions aimed at reducing healthcare utilization in COPD patients.